ASCO 2019 | The AVANOVA study: niraparib and bevacizumab for ovarian cancer

Mansoor Raza Mirza

In this video, Mansoor Raza Mirza, MD, of the Copenhagen University Hospital, Copenhagen, Denmark, discusses the AVANOVA study (NCT02354131) of niraparib and bevacizumab for treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video